Physician profile
Amy T Smith
NPI 1336378678
$6,248.93
in general payments reported to CMS, 2019-2025
24 companies · $1,554 in 2025
The $1,554 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $596 · 2022: $1,575 · 2023: $840 · 2024: $1,684 · 2025: $1,554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,696 · Education: $383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,695.59 |
| Education | $382.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,473.87 | 2021-2025 | |
| Janssen Biotech, INC. | $1,012.91 | 2023-2025 | Tremfya, Simponi, Simponi Aria |
| E.R. Squibb & Sons, L.L.C. | $495.49 | 2022-2025 | Sotyktu |
| Galderma Laboratories, L.P. | $478.66 | 2021-2025 | Aklief, Epsolay, Oracea |
| Lilly USA, LLC | $366.41 | 2021-2025 | Taltz, Ebglyss, Olumiant |
| Dermavant Sciences, INC. | $310.06 | 2022-2023 | Vtama |
| Arcutis Biotherapeutics, INC. | $304.56 | 2023-2025 | Zoryve |
| Genzyme Corporation | $263.62 | 2021-2025 | |
| Leo Pharma INC. | $262.50 | 2023-2025 | Adbry, Anzupgo |
| Pfizer INC. | $190.77 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $174.70 | 2021-2025 | |
| Hill Dermaceuticals, INC. | $148.32 | 2022 | |
| Novartis Pharmaceuticals Corporation | $146.12 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $110.98 | 2022-2025 | Spevigo |
| Paratek Pharmaceuticals, INC. | $100.00 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $85.46 | 2022-2025 | Opzelura |
| Ucb, INC. | $69.94 | 2022-2024 | Bimzelx, Cimzia |
| Almirall LLC | $50.32 | 2021-2022 | |
| Organon LLC | $47.34 | 2025 | Vtama |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $46.53 | 2021-2024 | Jublia, Arazlo, Cabtreo |
| Regeneron Healthcare Solutions, INC. | $43.78 | 2021-2024 | Dupixent, Libtayo |
| Elekta, INC. | $34.26 | 2025 | Flexitron Hdr |
| Amgen INC. | $16.35 | 2025 | Otezla |
| Vyne Pharmaceuticals INC. | $15.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.